Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.65M.
ENTERPRISE VALUE (EV)
$4.65M
Alzamend Neuro Inc
Market Cap
$5.36M
Enterprise Value (EV)
$4.65M
Market Cap
$6.03M
Enterprise Value (EV)
$3.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.36M | $4.65M |
| Imunon, Inc. (IMNN)vs › | $5.21M | $6.19M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | $8.40M |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | $11.59M |
| CalciMedica, Inc. (CALC)vs › | $4.85M | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | $1.00M |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | $3.98M |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | $17.82M |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | $879507.00 |
Market Cap
$5.36M
Total Debt
$0.00
Cash
$710689.00
Enterprise Value
$4.65M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
